Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Free Cash Flow (2024 - 2025)

Carlsmed (CARL) has disclosed Free Cash Flow for 2 consecutive years, with -$4.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow fell 17.36% year-over-year to -$4.8 million, compared with a TTM value of -$17.5 million through Dec 2025, changed N/A, and an annual FY2025 reading of -$29.0 million, down 13.95% over the prior year.
  • Free Cash Flow was -$4.8 million for Q4 2025 at Carlsmed, up from -$8.6 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$4.1 million in Q4 2024 and bottomed at -$8.6 million in Q3 2025.